【About Global Health Innovative Technology Fund】
The Global Health Innovative Technology Fund (GHIT Fund) is an international public-private fund in which the Japanese government (Ministry of Foreign Affairs, Ministry of Health, Labor and Welfare), private companies such as pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome Trust, and the United Nations Development Program participate. GHIT Fund has been investing in new drug development and portfolio management to contribute to global health, supporting Japanese technology and innovation to combat infectious diseases such as malaria, tuberculosis, and neglected tropical diseases (NTDs) that affect the world’s vulnerable and underserved populations. GHIT Fund promotes the participation of Japanese pharmaceutical companies, universities, and research institutes in product development, as well as collaboration with overseas institutions, in order to develop drugs, vaccines, and diagnostics.
For more information, please visit https://www.ghitfund.org/en
Shionogi participates in the Global Health Innovative Technology Fund
Shionogi contributes to the second phase of the Global Health Innovative Technology Fund
Notice of Collaboration Agreement for the Discovery and Development of Novel Malaria Drugs with Nagasaki University and MMV, Supported by the GHIT Fund
For Further Information, Contact:
SHIONOGI Website Inquiry Form : https://www.shionogi.com/global/en/contact.html